Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Rheumatoid Arthritis
•
General Rheumatology
•
TNF inhibitor
How do you manage transaminitis in a patient receiving TNF alpha inhibitors?
Related Questions
What is your approach to methotrexate use (or avoidance) in patients with varying MTHFR mutations?
Do you continue TNF inhibitors in patients with a new diagnosis of CLL?
For patients who do not have access to biologic therapies, what are some csDMARD combination pearls or tips that you have that have particular efficacy in different rheumatologic diseases?
How do you approach the treatment of patients with Ehlers-Danlos hypermobile type with chronic muscle spasms with minimal exertion?
How would you treat an asymptomatic patient with a positive Blastomyces antibody, evidence of prior granulomatous lung disease on imaging, and who may require immunosuppression in the future?
Is it ever safe to use a biologic DMARD in a patient with RA who is on suppressive antibiotics due to a history of septic prosthetic arthritis?
When screening for malignancy, do you order CT with contrast (or) both with and without contrast?
How do you approach treatment intensification in patients with RA and low disease activity but not in remission, considering the potential risks of increased immunosuppression?
What is the recommended fungal workup in an immunocompromised patient after 5 days of persistent fever?
What is your approach to diagnosing and managing methotrexate-induced alopecia?
